{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:25:53Z","timestamp":1790893553710,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.4158\/ep171828.ps","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T11:25:58Z","timestamp":1499945158000},"page":"869-881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":164,"title":["American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on Menopause\u20132017 Update"],"prefix":"10.1016","volume":"23","author":[{"given":"Rhoda H.","family":"Cobin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil F.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 6","key":"10.4158\/EP171828.PS_bb0010","article-title":"AACE medical guidelines for clinical practice for diagnosis and treatment of menopause","volume":"17","author":"Goodman","year":"2011","journal-title":"Endocr Pract"},{"key":"10.4158\/EP171828.PS_bb0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainres.2013.04.011","article-title":"Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS cognitive and affective sub study (KEEPS Cog)","volume":"1514","author":"Wharton","year":"2013","journal-title":"Brain Res"},{"key":"10.4158\/EP171828.PS_bb0020","unstructured":"NAMS 23rd Annual Meeting, Orlando, Florida, October 3\u20136, 2012. Available at: http:\/\/www.menopause.org\/annual-meetings\/2012-meeting\/keeps-report. Accessed May 25, 2017."},{"key":"10.4158\/EP171828.PS_bb0025","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1505241","article-title":"Vasuclar effects of early versus late postmenopausal treatment with estradiol","volume":"374","author":"Hodis","year":"2016","journal-title":"N Engl J Med"},{"key":"10.4158\/EP171828.PS_bb0030","doi-asserted-by":"crossref","first-page":"e6409","DOI":"10.1136\/bmj.e6409","article-title":"Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial","volume":"345","author":"Schierbeck","year":"2012","journal-title":"BMJ"},{"key":"10.4158\/EP171828.PS_bb0035","doi-asserted-by":"crossref","first-page":"e8146","DOI":"10.1136\/bmj.e8146","article-title":"Study had insufficient power to investigate safety","volume":"345","author":"Rossouw","year":"2012","journal-title":"BMJ"},{"key":"10.4158\/EP171828.PS_bb0040","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended posts stopping phases of the Women's Health Initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA"},{"key":"10.4158\/EP171828.PS_bb0045","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1373\/clinchem.2013.202556","article-title":"Menopausal hormone therapy and cardiovascular disease risk: utility of biomarkers and clinical factors for risk stratification","volume":"60","author":"Bassuk","year":"2014","journal-title":"Clin Chem"},{"key":"10.4158\/EP171828.PS_bb0050","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/gme.0b013e31826f80e0","article-title":"Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials","volume":"20","author":"Wild","year":"2013","journal-title":"Menopause"},{"key":"10.4158\/EP171828.PS_bb0055","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.fertnstert.2012.11.053","article-title":"Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS)","volume":"99","author":"Wolff","year":"2013","journal-title":"Fertil Steril"},{"key":"10.4158\/EP171828.PS_bb0060","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/gme.0b013e31819c11e4","article-title":"Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women","volume":"16","author":"Huang","year":"2009","journal-title":"Menopause"},{"key":"10.4158\/EP171828.PS_bb0065","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1161\/STROKEAHA.116.014674","article-title":"Menopausal hot flashes and carotid intima media thickness among midlife women","volume":"47","author":"Thurston","year":"2016","journal-title":"Stroke"},{"key":"10.4158\/EP171828.PS_bb0070","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/GME.0000000000000763","article-title":"Association of genetic variation in the tachykinin receptor 3 locus with hot flashes and night sweats in the Womens' Health Initiative Study","volume":"24","author":"Crandall","year":"2017","journal-title":"Menopause"},{"key":"10.4158\/EP171828.PS_bb0075","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/09513590.2012.730567","article-title":"Coagulation and fibrinolytic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration","volume":"29","author":"Po\u0142a\u0107","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.4158\/EP171828.PS_bb0080","first-page":"1052","article-title":"Comparison of estrogen and androgen levels after oral estrogen replacement therapy","volume":"46","author":"Slater","year":"2001","journal-title":"J Reprod Med"},{"issue":"suppl 1","key":"10.4158\/EP171828.PS_bb0085","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/13697137.2013.808563","article-title":"HRT optimization using transdermal estradiol plus micronized progesterone, a safer HRT","volume":"16","author":"L'Hermite","year":"2013","journal-title":"Climacteric"},{"key":"10.4158\/EP171828.PS_bb0090","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","article-title":"Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis","volume":"336","author":"Canonico","year":"2008","journal-title":"BMJ"},{"key":"10.4158\/EP171828.PS_bb0095","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1111\/j.1538-7836.2012.04919.x","article-title":"Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study","volume":"10","author":"Sweetland","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.4158\/EP171828.PS_bb0100","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/GME.0b013e31829a64f9","article-title":"Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study","volume":"21","author":"Shufelt","year":"2014","journal-title":"Menopause"},{"key":"10.4158\/EP171828.PS_bb0105","doi-asserted-by":"crossref","first-page":"c2519","DOI":"10.1136\/bmj.c2519","article-title":"Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study","volume":"340","author":"Renoux","year":"2010","journal-title":"BMJ"},{"key":"10.4158\/EP171828.PS_bb0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3171\/2014.12.JNS142329","article-title":"Hormone replacement therapy and the risk of subarachnoid hemorrhage in postmenopausal women","volume":"124","author":"Qureshi","year":"2016","journal-title":"J Neurosurg"},{"key":"10.4158\/EP171828.PS_bb0115","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.2007.13.4338","article-title":"Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer","volume":"26","author":"Fournier","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.4158\/EP171828.PS_bb0120","first-page":"843","article-title":"Breast cancer risk in older women: results from the NIH-AARP diet and health study","volume":"25","author":"Brinton","year":"2014","journal-title":"Cancer Causes Control"},{"key":"10.4158\/EP171828.PS_bb0125","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/oxfordjournals.humrep.a137138","article-title":"Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure","volume":"5","author":"Bourgain","year":"1990","journal-title":"Hum Reprod"},{"key":"10.4158\/EP171828.PS_bb0130","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/aje\/kwq300","article-title":"Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition","volume":"172","author":"Allen","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.4158\/EP171828.PS_bb0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/09513590.2015.1077382","article-title":"Luteal phase support in intrauterine insemination cycles: a prospective randomized study of 300 mg versus 600 mg intravaginal progesterone tablet","volume":"32","author":"Biberoglu","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"10.4158\/EP171828.PS_bb0140","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3109\/13697137.2011.644360","article-title":"Endometrial response to concurrent treatment with vaginal progesterone and transdermal estradiol","volume":"15","author":"Fern\u00e1ndez-Murga","year":"2012","journal-title":"Climacteric"},{"key":"10.4158\/EP171828.PS_bb0145","first-page":"CD000402","article-title":"Hormone therapy in postmenopausal women and risk of endometrial hyperplasia","volume":"8","author":"Furness","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.4158\/EP171828.PS_bb0150","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/ATVBAHA.109.196022","article-title":"Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study","volume":"30","author":"Canonico","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.4158\/EP171828.PS_bb0155","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jsbmb.2015.08.013","article-title":"Reprint of \u201cUse of medroxyprogesterone acetate for hormone therapy in postmenopausal women: Is it safe?\u201d","volume":"153","author":"Stanczyk","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.4158\/EP171828.PS_bb0160","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1200\/JCO.2003.05.151","article-title":"Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population","volume":"21","author":"Kerlikowske","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.4158\/EP171828.PS_bb0165","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/humupd\/dmi028","article-title":"Breast cancer risk with postmenopausal hormonal treatment","volume":"11","author":"Collins","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.4158\/EP171828.PS_bb0170","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ijc.20710","article-title":"Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort","volume":"114","author":"Fournier","year":"2005","journal-title":"Int J Cancer"},{"key":"10.4158\/EP171828.PS_bb0175","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/er.2012-1008","article-title":"Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects","volume":"34","author":"Stanczyk","year":"2013","journal-title":"Endocr Rev"},{"key":"10.4158\/EP171828.PS_bb0180","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1212\/WNL.0b013e318271f823","article-title":"Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study","volume":"79","author":"Shao","year":"2012","journal-title":"Neurology"},{"key":"10.4158\/EP171828.PS_bb0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/13697137.2016.1267723","article-title":"Menopause hormone therapy and diabetes","volume":"20","author":"Stuenkel","year":"2017","journal-title":"Climacteric"},{"key":"10.4158\/EP171828.PS_bb0190","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4065\/mcp.2010.0714","article-title":"Bioidentical hormone therapy","volume":"86","author":"Files","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.4158\/EP171828.PS_bb0195","unstructured":"GalsonSK.Pharmacy Compounding\/Compounding of Bio-identical Hormone Replacement Therapies. Available at: https:\/\/www.fda.gov\/newsevents\/testimony\/ucm154031.htm. Accessed May 31, 2017."},{"key":"10.4158\/EP171828.PS_bb0200","unstructured":"Available at: http:\/\/www.fda.gov\/forconsumers\/byaudience\/forwomen\/ucm118624.htm."},{"key":"10.4158\/EP171828.PS_bb0205","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1586\/17512433.2014.893819","article-title":"Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy","volume":"7","author":"Sharifi","year":"2014","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.4158\/EP171828.PS_bb0210","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.maturitas.2013.06.003","article-title":"Tissue-selective estrogen complexes for postmenopausal women","volume":"76","author":"Mirkin","year":"2013","journal-title":"Maturitas"},{"key":"10.4158\/EP171828.PS_bb0215","unstructured":"Rosen HN, Rosen CJ, Mulder JE.. Selective estrogen receptor modulators, Up to Date. 2017;."},{"key":"10.4158\/EP171828.PS_bb0220","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/bph.13622","article-title":"The potential health effects of dietary phytoestrogens","volume":"174","author":"Rietjens","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.4158\/EP171828.PS_bb0225","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/AOG.0000000000000927","article-title":"Pooled analysis of six pharmacologic and nonpharmacologic interventions for vasomotor symptoms","volume":"126","author":"Guthrie","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.4158\/EP171828.PS_bb0230","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2147\/IJWH.S50804","article-title":"Critical appraisal of paroxetine for the treatment of vasomotor symptoms","volume":"7","author":"Carroll","year":"2015","journal-title":"Int J Womens Health"},{"key":"10.4158\/EP171828.PS_bb0235","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10549-013-2585-z","article-title":"Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen","volume":"139","author":"Binkhorst","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.4158\/EP171828.PS_bb0240","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5539\/gjhs.v5n6p126","article-title":"The effect of gabapentin on intensity and duration of hot flashes in postmenopausal women: a randomized controlled trial","volume":"5","author":"Saadati","year":"2013","journal-title":"Glob J Health Sci"},{"key":"10.4158\/EP171828.PS_bb0245","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/GME.0b013e3182a7c073","article-title":"Phase 3 randomized controlled study of gastro-retentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause","volume":"21","author":"Pinkerton","year":"2014","journal-title":"Menopause"},{"key":"10.4158\/EP171828.PS_bb0250","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1200\/JCO.2010.29.9230","article-title":"Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors","volume":"28","author":"Bordeleau","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.4158\/EP171828.PS_bb0255","first-page":"1461","article-title":"Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations","volume":"21","author":"L'Esp\u00e9rance","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.4158\/EP171828.PS_bb0260","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/138620708784246022","article-title":"High-content screening and mechanism-based evaluation of estrogenic botanical extracts","volume":"11","author":"Overk","year":"2008","journal-title":"Comb Chem High Throughput Screen"},{"key":"10.4158\/EP171828.PS_bb0265","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2210-7-11","article-title":"Gene expression profiling reveals effects of Cimicifuga racemosa (L.) NUTT. (black cohosh) on the estrogen receptor positive human breast cancer cell line MCF-7","volume":"7","author":"Gaube","year":"2007","journal-title":"BMC Pharmacol"},{"key":"10.4158\/EP171828.PS_bb0270","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.taap.2012.05.022","article-title":"An ethanolic extract of black cohosh causes hematological changes but not estrogenic effects in female rodents","volume":"263","author":"Mercado-Feliciano","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.4158\/EP171828.PS_bb0275","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jsbmb.2007.03.044","article-title":"Estrogen-like effect of a Cimicifuga racemosa extract sub-fraction as assessed by in vivo, ex vivo and in vitro assays","volume":"107","author":"Bolle","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.4158\/EP171828.PS_bb0280","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1534735413477191","article-title":"Black cohosh and breast cancer: a systematic review","volume":"13","author":"Fritz","year":"2014","journal-title":"Integr Cancer Ther"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20357931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20357931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:03:21Z","timestamp":1761516201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20357931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1530891X20357931"],"URL":"https:\/\/doi.org\/10.4158\/ep171828.ps","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on Menopause\u20132017 Update","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP171828.PS","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}